166 related articles for article (PubMed ID: 11231342)
21. Hepatocyte growth factor-induced amelioration in renal interstitial fibrosis is associated with reduced expression of alpha-smooth muscle actin and transforming growth factor-beta1.
Wang HY; Wang YJ; Cui MJ; Gu CM; Yang LZ; Zhao Y; Chen Y; Zhao D; Li TS; Chi BR
Indian J Biochem Biophys; 2011 Oct; 48(5):308-15. PubMed ID: 22165288
[TBL] [Abstract][Full Text] [Related]
22. Correlations between renal cortical interstitial fibrosis, atrophy of the proximal tubules and impairment of the glomerular filtration rate.
Mackensen-Haen S; Bader R; Grund KE; Bohle A
Clin Nephrol; 1981 Apr; 15(4):167-71. PubMed ID: 7237863
[TBL] [Abstract][Full Text] [Related]
23. Expression of insulin-like growth factor-I and transforming growth factor-beta in hypokalemic nephropathy in the rat.
Tsao T; Fawcett J; Fervenza FC; Hsu FW; Huie P; Sibley RK; Rabkin R
Kidney Int; 2001 Jan; 59(1):96-105. PubMed ID: 11135062
[TBL] [Abstract][Full Text] [Related]
24. Induction of heme oxygenase-1 can halt and even reverse renal tubule-interstitial fibrosis.
Correa-Costa M; Semedo P; Monteiro AP; Silva RC; Pereira RL; Gonçalves GM; Marques GD; Cenedeze MA; Faleiros AC; Keller AC; Shimizu MH; Seguro AC; Reis MA; Pacheco-Silva A; Câmara NO
PLoS One; 2010 Dec; 5(12):e14298. PubMed ID: 21179206
[TBL] [Abstract][Full Text] [Related]
25. Renal and cardiovascular effects of renal medullary damage with bromoethylamine in dogs.
Szenasi G; Alcorn D; Anderson WP
Blood Press; 1994 Mar; 3(1-2):127-36. PubMed ID: 8199713
[TBL] [Abstract][Full Text] [Related]
26. Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy.
Huuskes BM; Wise AF; Cox AJ; Lim EX; Payne NL; Kelly DJ; Samuel CS; Ricardo SD
FASEB J; 2015 Feb; 29(2):540-53. PubMed ID: 25395452
[TBL] [Abstract][Full Text] [Related]
27. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
[TBL] [Abstract][Full Text] [Related]
28. Acute cortical tubular necrosis in the Swiss ICR mouse induced by 2-bromoethylamine hydrobromide.
Wolf DC; Carlton WW
Food Chem Toxicol; 1990 May; 28(5):351-60. PubMed ID: 2379894
[TBL] [Abstract][Full Text] [Related]
29. Morphometry of interstitial fibrosis.
De Heer E; Sijpkens YW; Verkade M; den Dulk M; Langers A; Schutrups J; Bruijn JA; van Es LA
Nephrol Dial Transplant; 2000; 15 Suppl 6():72-3. PubMed ID: 11143998
[TBL] [Abstract][Full Text] [Related]
30. Relaxin ameliorates salt-sensitive hypertension and renal fibrosis.
Yoshida T; Kumagai H; Suzuki A; Kobayashi N; Ohkawa S; Odamaki M; Kohsaka T; Yamamoto T; Ikegaya N
Nephrol Dial Transplant; 2012 Jun; 27(6):2190-7. PubMed ID: 22086971
[TBL] [Abstract][Full Text] [Related]
31. The mTOR inhibitor everolimus attenuates tacrolimus-induced renal interstitial fibrosis in rats.
Shigematsu T; Tajima S; Fu R; Zhang M; Itoyama Y; Tsuchimoto A; Egashira N; Ieiri I
Life Sci; 2022 Jan; 288():120150. PubMed ID: 34793770
[TBL] [Abstract][Full Text] [Related]
32. Targeting renal macrophage accumulation via c-fms kinase reduces tubular apoptosis but fails to modify progressive fibrosis in the obstructed rat kidney.
Ma FY; Liu J; Kitching AR; Manthey CL; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2009 Jan; 296(1):F177-85. PubMed ID: 18987110
[TBL] [Abstract][Full Text] [Related]
33. [Effects of urokinase on renal interstitial fibrosis and transforming growth factor-beta1 in the kidney of rats with chronic cyclosporine A nephropathy].
Wang Y; Tong JR; Luo ZM; He F; Ma L
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2449-52. PubMed ID: 20034899
[TBL] [Abstract][Full Text] [Related]
34. [Expression and mechanism of osteoactivin in the kidney of SD rats after acute cyclosporine A toxicity].
Ye M; Xie X; Peng L; Tan L; Lan G; Yu S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 36(9):881-8. PubMed ID: 21946207
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy.
Mizuno S; Matsumoto K; Nakamura T
Kidney Int; 2001 Apr; 59(4):1304-14. PubMed ID: 11260391
[TBL] [Abstract][Full Text] [Related]
36. Relaxin-induced changes in renal function and RXFP1 receptor expression in the female rat.
Bogzil AH; Ashton N
Ann N Y Acad Sci; 2009 Apr; 1160():313-6. PubMed ID: 19416210
[TBL] [Abstract][Full Text] [Related]
37. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
Wang SN; LaPage J; Hirschberg R
Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
[TBL] [Abstract][Full Text] [Related]
38. Relaxin Ameliorates Renal Fibrosis and Expression of Endothelial Cell Transition Markers in Rats of Isoproterenol-Induced Heart Failure.
Zheng G; Cai J; Chen X; Chen L; Ge W; Zhou X; Zhou H
Biol Pharm Bull; 2017; 40(7):960-966. PubMed ID: 28674260
[TBL] [Abstract][Full Text] [Related]
39. Protein kinase C inhibitor prevents renal apoptotic and fibrotic changes in response to partial ureteric obstruction.
Juan YS; Chuang SM; Long CY; Lin RJ; Liu KM; Wu WJ; Huang CH
BJU Int; 2012 Jul; 110(2):283-92. PubMed ID: 22145940
[TBL] [Abstract][Full Text] [Related]
40. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
Banković-Calić N; Ogbori MR; Nicman E
Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
